| Application no. and date | 18720895.4 (espacenet) (Federated) (European Patent Register), 20180409 | | Patent/reg. no. and date | DK/EP 3609497, 20221012 | | Publication date | 20200219 | | Priority no. and date | US 201762485164 P, 20170413 | | EP pub. no. and date |
EP 3609497 20200219 | | Effective date | | | Applicant/owner | Janssen Pharmaceutica NV, Turnhoutseweg 30
2340 Beerse, BE | | Applicant ref. no. | P80869DK01 | | Inventor | YU, Margaret K., 10990 Wilshire Blvd., Suite 300
Los Angeles, California 90024, US,
SNYDER, Linda Anne, 1400 McKean Road
Spring House, Pennsylvania 19477, US | | Representative | Plougmann Vingtoft A/S, Strandvejen 70, 2900 Hellerup, DK | | Opponent | | | IPC Class | A61K 31/454 (2006.01) , A61K 31/573 (2006.01) , A61K 31/58 (2006.01) , A61P 35/00 (2006.01) | | Title | NIRAPARIB, ABIRATERONACETAT OG PREDNISON TIL BEHANDLING AF PROSTATAKRÆFT | | Int. application no. | US2018026661 | | Int. publication no. | WO2018191141 | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
